The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The lawsuit, filed in the District Court of the District of Columbia, alleges that the agency did not abide by the mandatory timelines. (Michal Chodyra/Getty Images) Once again, Vanda Pharmaceuticals ...

WASHINGTON, Dec. 20, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849A, a selective ...

View Vanda Pharmaceuticals Inc. VNDA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Vanda asked Martin Makary, the Commissioner of the Food and Drug Administration, to review the decision made by Jacqueline Corrigan-Curay, the departing director of the FDA's Center for Drug ...

Vanda Pharmaceuticals has been seeking an FDA approval for Hetlioz to treat jet lag disorder, but the yearslong effort appears to have ended in disappointment. (Alina Rosanova/iStock/Getty Images Plus ...

Add The Drive (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results The car ...

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA), a biopharmaceutical company announced on Monday, that it has accepted the FDA's offer for a hearing regarding its New Drug Application or NDA for ...

This morning Vanda, a global leader of high-frequency positioning data and tactical macro insights and Exante Data Inc, an innovative data analytics and global macro strategy provider announced they ...

The Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) issued a notice summarizing the grounds for refusing a new drug application (NDA) ...